Outset Medical to Present at the 2024 Stifel Healthcare Conference
2024年11月15日 - 11:00PM
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology
company pioneering a first-of-its-kind technology to reduce the
cost and complexity of dialysis, today announced that members of
management will present at the 2024 Stifel Healthcare conference on
Tuesday, November 19, 2024, at 10:20 a.m. Eastern time.
A live and archived webcast of the presentation
will be available on the “Investors” section of the Outset website
at https://investors.outsetmedical.com/.
About Outset Medical,
Inc.Outset is a medical technology company pioneering a
first-of-its-kind technology to reduce the cost and complexity of
dialysis. The Tablo® Hemodialysis System, FDA cleared for use from
the hospital to the home, represents a significant technological
advancement that transforms the dialysis experience for patients
and operationally simplifies it for providers. Tablo serves as a
single enterprise solution that can be utilized across the
continuum of care, allowing dialysis to be delivered anytime,
anywhere and by anyone. The integration of water purification and
on-demand dialysate production enables Tablo to serve as a dialysis
clinic on wheels, with 2-way wireless data transmission and a
proprietary data analytics platform powering a new holistic
approach to dialysis care. Tablo is a registered trademark of
Outset Medical, Inc.
ContactJim Mazzola Investor
Relations jmazzola@outsetmedical.com
Outset Medical (NASDAQ:OM)
過去 株価チャート
から 10 2024 まで 11 2024
Outset Medical (NASDAQ:OM)
過去 株価チャート
から 11 2023 まで 11 2024